We found that the high-risk patients had lower infiltrating levels of CD4 + T cells and dendritic cells than low-risk patients, which validated and expanded the results that the heterogeneity of immune infiltration was vital for the progression of ccRCC. The gene discussed is CD4; the disease is nonpapillary renal cell carcinoma.